Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
Led by Santé, the funding will support completion of the world’s first randomized HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company’s anesthesia-free, outpatient sonic therapy PALO ALTO, Calif., April 15, 2026 /PRNewswire/ — Sonire Therapeutics,... Read More →
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives of babies and mothers around the world. NEW YORK, April 14, 2026 /PRNewswire/ — A breakthrough in fetal brain monitoring developed at... Read More →
Sibel Health Receives FDA-Clearance for ANNE® Maternal, a Comprehensive and Fully Wireless Maternal-Fetal Monitoring Platform
CHICAGO, April 9, 2026 /PRNewswire/ — Sibel Health today announced FDA 510(k) clearance of ANNE® Maternal, the world’s first fully wireless, comprehensive maternal-fetal monitoring platform. Designed for continuous, simultaneous monitoring of maternal and fetal health, ANNE® Maternal combines advanced wearable... Read More →
FDA Clears InVera Infusion Device to Treat Chronic Venous Disease
April 8, 2026—InVera Medical announced FDA 510(k) clearance for the InVera infusion device for the minimally invasive treatment of diseased leg veins, including varicose veins. The device is now approved for use in the United States and European Union within... Read More →
How Genalyte Is Turning Same-Visit Diagnostics Into Lifesaving Decisions
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
AI-Enhanced ECG flags aortic stenosis years before symptoms featuring AccurKardia
Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis. Because echocardiography is effective but not scalable for population screening, his team applied the previously... Read More →
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the... Read More →
Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness
Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and Sonder Capital. Utrecht, The Netherlands, March 10, 2026 – Vitestro, the pioneer... Read More →
May Health Raises $11.7M to Advance its Novel Technology to Treat PCOS-related Infertility
New investor Nexpring Health™ joins existing investors, including Sofinnova, Bpifrance, and Trill Impact MENLO PARK, Calif.–(BUSINESS WIRE)–May Health, a medical device company dedicated to helping women living with polycystic ovary syndrome (PCOS), today announced that it raised €10 million ($11.7M)... Read More →
From animal models to organoids: how functional data fits regulatory expectations featuring Diagnostic Biochips
The landscape of preclinical neuroscience research is shifting. Growing ethical considerations, cost pressures, and translational limitations have accelerated interest in organoid alternatives to animal models in neuroscience. While animal models have long served as the foundation for safety and efficacy... Read More →